Delivery Order SPE2DB20D2104-SPE2DB24FMCAE

Award Date 9/20/24
Potential Completion Date 9/23/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,058.12 firm fixed-price delivery order is for the supply of hydroxyzine 50 mg/ml vials. The contract has an ultimate completion date of July 30, 2024 and was awarded on July 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to...
The Defense Logistics Agency (DLA) awarded a $1,056.01 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp Corporate Office Division to supply 100-count bottles of 25 mg hydroxyzine PAM capsules. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a range of pharmaceutical and medical commodities to support military treatment programs and facilities worldwide. The...
This federal contract award, with ID SPE2DX15D7068|SPE2DX24F2KFP, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $2,788.13 firm-fixed-price delivery order is for the supply of 500 units of the drug hydroxyzine PAM 25 mg capsules. The contract has a completion date of July 16, 2024. Amerisourcebergen holds a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,810.40, is for the delivery of 4567445230 - Hydroxyzine 50 mg/mL vials. The contract is a Firm Fixed Price Delivery Order with a completion date of March 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4563927988 - Hydroxyzine PAM 25 mg capsules in units of 100. The contract has an ultimate completion date of March 12, 2024 and a ceiling value of $1,869.82. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical products and medical supplies to U.S....
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,768.26, is for the delivery of 4565313651 - Hydroxyzine 50 mg/mL vial. The contract is a delivery order issued under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to...
This federal contract award, valued at $37,433.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of 500 units of the drug Hydroxyzine Hydrochloride 10 mg Tablets. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, with the ID SPE2DB22D1106|SPE2DB24FFDC3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,159.94 firm fixed-price delivery order is for the supply of 4,565,213,694 units of the medication Hydroxyzine HCL 10 mg tablet, with a completion date of July 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,250.02 firm fixed-price delivery order is for the supply of 4557963146 - Hydroxyzine HCL 25 mg Tablets in quantities of 500s. There is no set-aside designation, indicating this was an open competition. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
This is a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,531.53, is for the delivery of hydroxyzine 50 mg/ml vial. The award is a delivery order against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FMCAE
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,536.56 firm fixed-price delivery order is for the supply of 500 units of Hydroxyzine PAM 25 mg capsules. The contract has an ultimate completion date of September 23, 2024 and was awarded on September 20, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables efficient government procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award has no set-aside designation, indicating open competition.

Generated 2/27/25, 11:45 AM